KRT19 and neoplasm: An evaluation of molecular signatures based on tumor expression of 20 metastasis-associated microRNAs [42], a comparison of microRNA expression between tumor and adjacent benign tissue [43], or the tumor expression of five genes (HN1, RAN, RAMP3, KRT19 and TAF9) [44] can also predict prognosis.